{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:26:53Z","timestamp":1775064413121,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1799,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1194\/jlr.m061275","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T02:59:30Z","timestamp":1440730770000},"page":"1936-1946","source":"Crossref","is-referenced-by-count":45,"title":["Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr mice by targeting the TGF\u03b2-Smad3 pathway"],"prefix":"10.1016","volume":"56","author":[{"given":"Kelli A.","family":"Lytle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Depner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen P.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald B.","family":"Jump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M061275_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M061275_bib2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology."},{"key":"10.1194\/jlr.M061275_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"Suppl 1","key":"10.1194\/jlr.M061275_bib4","first-page":"S17","article-title":"Pathophysiology of nonalcoholic steatohepatitis","volume":"40","author":"McCullough","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1194\/jlr.M061275_bib5","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"57","author":"Prashanth","year":"2009","journal-title":"J. Assoc. Physicians India."},{"key":"10.1194\/jlr.M061275_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"Soderberg","year":"2010","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M061275_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M061275_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1194\/jlr.M061275_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease","volume":"8","author":"McCullough","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"Suppl 4","key":"10.1194\/jlr.M061275_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist."},{"key":"10.1194\/jlr.M061275_bib11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science."},{"key":"10.1194\/jlr.M061275_bib12","doi-asserted-by":"crossref","first-page":"16464","DOI":"10.3748\/wjg.v20.i44.16464","article-title":"Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development","volume":"20","author":"Jiang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1194\/jlr.M061275_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s12328-014-0548-5","article-title":"Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies","author":"Oda","year":"2015","journal-title":"Clin. J. Gastroenterol."},{"key":"10.1194\/jlr.M061275_bib14","first-page":"9217","article-title":"Could metabolic syndrome lead to hepatocellular carcinoma via non-alcoholic fatty liver disease?","volume":"20","author":"Scalera","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1194\/jlr.M061275_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1751-2980.2010.00469.x","article-title":"Epidemiology of the metabolic syndrome in the USA","volume":"12","author":"McCullough","year":"2011","journal-title":"J. Dig. Dis."},{"key":"10.1194\/jlr.M061275_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteases in liver injury, repair and fibrosis","volume":"44\u201366C","author":"Duarte","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1194\/jlr.M061275_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosa\u00adhexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(\u2212\/\u2212) mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"Depner","year":"2013","journal-title":"J. Nutr."},{"key":"10.1194\/jlr.M061275_bib18","doi-asserted-by":"crossref","first-page":"e83756","DOI":"10.1371\/journal.pone.0083756","article-title":"A metabolomic analysis of omega-3 fatty acid mediated attenuation of western diet-induced non-alcoholic steatohepatitis in LDLR\u2212\/\u2212 mice","volume":"8","author":"Depner","year":"2013","journal-title":"PLoS One."},{"key":"10.1194\/jlr.M061275_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ajcn.81.2.341","article-title":"Orgins and evolution of the western diet: health implications for the 21st century","volume":"81","author":"Cordain","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.M061275_bib20","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M061275_bib21","doi-asserted-by":"crossref","first-page":"212865","DOI":"10.1155\/2012\/212865","article-title":"Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity","volume":"2012","author":"Guturu","year":"2012","journal-title":"Int. J. Hepatol."},{"key":"10.1194\/jlr.M061275_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M061275_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1194\/jlr.M061275_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease","volume":"7","author":"Harte","year":"2010","journal-title":"J. Inflamm. (Lond)."},{"key":"10.1194\/jlr.M061275_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1194\/jlr.R008896","article-title":"Genetic determinants of hepatic steatosis in man","volume":"52","author":"Hooper","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M061275_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1194\/jlr.M061275_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature."},{"key":"10.1194\/jlr.M061275_bib28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3945\/jn.112.158865","article-title":"Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr\u2212\/\u2212 mice","volume":"142","author":"Depner","year":"2012","journal-title":"J. Nutr."},{"key":"10.1194\/jlr.M061275_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-nutr-071812-161139","article-title":"Fatty acid-regulated transcription factors in the liver","volume":"33","author":"Jump","year":"2013","journal-title":"Annu. Rev. Nutr."},{"key":"10.1194\/jlr.M061275_bib30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial","volume":"96","author":"Nobili","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1194\/jlr.M061275_bib31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/09637486.2010.487480","article-title":"Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study","volume":"61","author":"Sofi","year":"2010","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1194\/jlr.M061275_bib32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/MEG.0b013e32833b257a","article-title":"Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis","volume":"22","author":"Bulchandani","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1194\/jlr.M061275_bib33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1253\/circj.CJ-09-0520","article-title":"Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease","volume":"74","author":"Ishikawa","year":"2010","journal-title":"Circ. J."},{"key":"10.1194\/jlr.M061275_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/CCLM.2011.020","article-title":"Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury","volume":"49","author":"Kishino","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1194\/jlr.M061275_bib35","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"WELCOME study. Effects of purified eicosapentaenoic and docosahexaenoic acids in non-alcoholic fatty liver disease: results from the WELCOME study","volume":"60","author":"Scorletti","year":"2014","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M061275_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"Argo","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1194\/jlr.M061275_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentaenoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1194\/jlr.M061275_bib38","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2008.05.056","article-title":"Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia","volume":"102","author":"Barter","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.M061275_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00228-004-0758-8","article-title":"Early modification of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 PUFA","volume":"60","author":"Di Stasi","year":"2004","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1194\/jlr.M061275_bib40","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/CIRCULATIONAHA.113.002731","article-title":"Omega-3 fatty acid blood levels. Clinical significance and controversy","volume":"128","author":"Superko","year":"2013","journal-title":"Circulation."},{"key":"10.1194\/jlr.M061275_bib41","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1017\/S0007114511007082","article-title":"STAT gene dietary model to implement diets of differing fat composition in prospectively genotyped groups (apoE) using commercially available foods","volume":"108","author":"Lockyer","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1194\/jlr.M061275_bib42","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1194\/jlr.M006080","article-title":"Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL\/6J mice","volume":"51","author":"Tripathy","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M061275_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for the analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut."},{"key":"10.1194\/jlr.M061275_bib44","doi-asserted-by":"crossref","first-page":"e75692","DOI":"10.1371\/journal.pone.0075692","article-title":"Genetic characteristics of the human hepatic stellate cell line LX-2","volume":"8","author":"Weiskirchen","year":"2013","journal-title":"PLoS One."},{"key":"10.1194\/jlr.M061275_bib45","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1194\/jlr.M050062","article-title":"Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL\/6J mice","volume":"55","author":"Tripathy","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M061275_bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2010.12.014","article-title":"Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation","volume":"81","author":"Jump","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M061275_bib47","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.M061275_bib48","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M061275_bib49","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jgh.12924","article-title":"Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis","volume":"30","author":"Cengiz","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"10.1194\/jlr.M061275_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1194\/jlr.M061275_bib51","first-page":"109","article-title":"TLR4 as the mammalian endotoxin sensor","volume":"270","author":"Beutler","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1194\/jlr.M061275_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2015.01.002","article-title":"Adipocytokines and hepatic fibrosis","volume":"26","author":"Saxena","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1194\/jlr.M061275_bib53","doi-asserted-by":"crossref","first-page":"G723","DOI":"10.1152\/ajpgi.00414.2010","article-title":"Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophage","volume":"300","author":"Barron","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1194\/jlr.M061275_bib54","doi-asserted-by":"crossref","first-page":"G605","DOI":"10.1152\/ajpgi.00222.2012","article-title":"Hepatic stellate cells and portal fibrosis are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury","volume":"304","author":"Perepelyuk","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1194\/jlr.M061275_bib55","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF-\u03b2 signalling in context","volume":"13","author":"Massague","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1194\/jlr.M061275_bib56","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF-\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1194\/jlr.M061275_bib57","first-page":"945","article-title":"TGF-\u03b2 signaling and its targeting for glioma treatment","volume":"5","author":"Han","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1194\/jlr.M061275_bib58","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.3748\/wjg.v20.i41.15018","article-title":"Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepacellular carcinoma","volume":"20","author":"Murata","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1194\/jlr.M061275_bib59","doi-asserted-by":"crossref","first-page":"17058","DOI":"10.1074\/jbc.M100754200","article-title":"Identification of novel TGF-\u03b2\/Smad gene targets in dermal fibroblast using a combined cRNA microarray\/promoter transactivation approach","volume":"276","author":"Verrecchia","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M061275_bib60","doi-asserted-by":"crossref","first-page":"ra1","DOI":"10.1126\/scisignal.2005379","article-title":"The kinase activity of the Ser\/Thr kinase Bub1 promotes TGF-\u03b2 signaling","volume":"8","author":"Nyati","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1194\/jlr.M061275_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1388-1981(00)00077-9","article-title":"Metabolism of highly unsaturated n-3 and n-6 fatty acids","volume":"1486","author":"Sprecher","year":"2000","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M061275_bib62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbalip.2014.12.003","article-title":"Role of long-chain acyl-CoA synthetase 4 in formation of polyunsaturated lipid species in hepatic stellate cells","volume":"1851","author":"Tuohetahuntila","year":"2015","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M061275_bib63","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1194\/jlr.M061275_bib64","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1038\/cddis.2014.294","article-title":"Caveolin-1 is required for TGF\u03b2-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACD\/ADAM17","volume":"5","author":"Moreno-Caceres","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1194\/jlr.M061275_bib65","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jnutbio.2013.01.007","article-title":"Regulation of thrombospondin-1 expression in alternatively activated macrophage and adipocytes: role of cellular crosstalk and omega-3 fatty acids","volume":"24","author":"Finlin","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1194\/jlr.M061275_bib66","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0002-9440(10)63259-2","article-title":"Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"165","author":"Park","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M061275_bib67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/02713683.2013.877936","article-title":"Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation","volume":"39","author":"Masli","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1194\/jlr.M061275_bib68","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E14-05-0996","article-title":"Inter-molecular interactions of thrombospondins drive their accumulation in extracellular matrix","author":"Kim","year":"2015","journal-title":"Mol. Biol. Cell."},{"key":"10.1194\/jlr.M061275_bib69","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jnutbio.2010.11.022","article-title":"Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats","volume":"23","author":"Chen","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1194\/jlr.M061275_bib70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2466-14-64","article-title":"Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis","volume":"14","author":"Zhao","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1194\/jlr.M061275_bib71","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M061275_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yexmp.2014.12.006","article-title":"The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced fatty accumulation","volume":"98","author":"Giraudi","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1194\/jlr.M061275_bib73","doi-asserted-by":"crossref","first-page":"592S","DOI":"10.3945\/jn.111.155259","article-title":"Mechanisms of action of (n-3) fatty acids","volume":"142","author":"Calder","year":"2012","journal-title":"J. Nutr."},{"key":"10.1194\/jlr.M061275_bib74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.5876","article-title":"Relationships between plasma fatty acid composition and coronary artery disease","volume":"18","author":"Itakura","year":"2011","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1194\/jlr.M061275_bib75","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1194\/jlr.R027904","article-title":"Omega-3 fatty acid supplementation and cardiovascular disease","volume":"53","author":"Jump","year":"2012","journal-title":"J. Lipid Res."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752030969X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752030969X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M061275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T15:31:21Z","timestamp":1637422281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002222752030969X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S002222752030969X"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m061275","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}